The secreted EGF-Discoidin factor xDel1 is essential for dorsal development of the Xenopus embryo.

A. Arakawa,M. Matsuo‐Takasaki,A. Takai,Hidehiko Inomata,Michiru Matsumura,M. Ikeya,Kenzo Takahashi,Y. Miyachi,Noriaki Sasai,Y. Sasai

DOI: https://doi.org/10.1016/J.YDBIO.2007.03.008

IF: 3.148

2007-06-01

Developmental Biology

Abstract:

What problem does this paper attempt to address?

Atrial Natriuretic Peptide Attenuates Colitis Via Inhibition of the Cgas-Sting Pathway in Colonic Epithelial Cells

Chaoyue Chen,Ying Zhang,Meihui Tao,Xi Zhao,Qinyu Feng,Xiaoshang Fei,Yu Fu

DOI: https://doi.org/10.7150/ijbs.67356

2022-01-01

International Journal on Biological Sciences

Abstract:Atrial Natriuretic Peptide (ANP) has known anti-inflammatory effects. However, the role of ANP in Ulcerative colitis (UC) remains unclear. This study aimed to explore the expression and function of ANP in UC, and its potential regulatory role in the stimulator of interferon genes (STING) pathway. Human colon biopsy and serum samples were collected between September 2018 and December 2019 at Wuhan Union Hospital. Levels of ANP and its receptors and STING pathway components were detected in people with UC and mice with dextran sulfate sodium (DSS)-induced colitis. These mice and HT-29 cells were treated with ANP and an agonist of the STING pathway. The level of inflammation, STING pathway, gut barrier, and endoplasmic reticulum (ER) stress-induced autophagy were measured. We found that the levels of ANP and its receptor decreased and the STING pathway activated statistically in people with UC and the mouse model of colitis. ANP treatment attenuated DSS-induced colitis and inhibited STING pathway phosphorylation in colonic tissue and epithelial cells. An interaction between cGAS and NPR-A was verified. ANP repaired the gut barrier and inhibited ER stress-induced autophagy via the STING pathway. ANP may thus alter colonic barrier function and regulate ER stress-induced autophagy as a promising therapy for UC.
Regulation of the Ischemia-Induced Autophagy-Lysosome Processes by Nitrosative Stress in Endothelial Cells.

Feng Han,Ying-xian Chen,Ying-mei Lu,Ji-yun Huang,Gen-sheng Zhang,Rong-rong Tao,Yue-long Ji,Mei-hua Liao,Kohji Fukunaga,Zheng-hong Qin

DOI: https://doi.org/10.1111/j.1600-079x.2011.00869.x

2011-01-01

Journal of Pineal Research

Abstract:The cellular mechanisms that underlie the diverse nitrosative stress-mediated cellular events associated with ischemic complications in endothelial cells are not yet clear. To characterize whether autophagic elements are associated with the nitrosative stress that causes endothelial damage after ischemia injury, an in vitro sustained oxygen-glucose deprivation (OGD) and an in vivo microsphere embolism model were used in the present study. Consistent with OGD-induced peroxynitrite formation, a rapid induction of microtubule-associated protein 1 light chain 3 (LC3)-I/II conversion and green fluorescent protein-LC3 puncta accumulation were observed in endothelial cells. The Western blot analyses indicated that OGD induced elevations in lysosome-associated membrane protein 2 and cathepsin B protein levels. Similar results were observed in the microvessel insult model, following occlusion of the microvessels using microsphere injections in rats. Furthermore, cultured endothelial cells treated with peroxynitrite (1-50 mu m) exhibited a concentration-dependent change in the pattern of autophagy-lysosome signaling. Intriguingly, OGD-induced autophagy-lysosome processes were attenuated by PEP-19 overexpression and by a small-interfering RNA (siRNA)-mediated knockdown of eNOS. The importance of nitrosative stress in ischemia-induced autophagy-lysosome cascades is further supported by our finding that pharmacological inhibition of nitrosative stress by melatonin partially inhibits the ischemia-induced autophagy-lysosome cascade and the degradation of the tight junction proteins. Taken together, the present results demonstrate that peroxynitrite-mediated nitrosative stress at least partially potentiates autophagy-lysosome signaling during sustained ischemic insult-induced endothelial cell damage.
Luminescent lanthanide complexes with stereocontrolled tris(2-pyridylmethyl)amine ligands: chirality effects on lanthanide complexation and luminescence properties.

Takashi Yamada,S. Shinoda,H. Sugimoto,J. Uenishi,H. Tsukube

DOI: https://doi.org/10.1021/IC020726R

IF: 4.6

2003-10-28

Inorganic Chemistry

Abstract:A series of tris(2-pyridylmethyl)amines including one and two asymmetric centers were synthesized in a stereo-controlled fashion as potential ligands of lanthanide cations. The reaction of chiral pyridylethyl methanesulfonates and bis(pyridylmethyl)amines occurred via an S(N)2 mechanism with complete inversion of asymmetric centers and gave the stereocontrolled tris(2-pyridylmethyl)amines, the stereochemical purity of which was ascertained by GPC, NMR, X-ray, and polarimetry experiments. They formed stable Tb(3+) and Eu(3+) complexes having 1:1, 1:2, and 1:3 stoichiometry (metal:ligand) in CH(3)CN solutions. NMR and UV titration experiments revealed that their complexation behaviors were rarely influenced by ligand chirality but significantly affected by the nature of the counteranion and the concentration ratio of metal to ligand. The Tb(3+) and Eu(3+) complexes with these tripodal ligands exhibited characteristic luminescence spectra upon excitation for pyridine chromophores (260 nm), the intensities of which were largely dependent on the ligand chirality. The meso isomer of the disubstituted tripods particularly exhibited the enhanced terbium luminescence ca. three times more than its diastereomer and un- and monosubstituted tripods. Direct excitation at the lanthanide center had similar chirality effects on the luminescence profiles, indicating that the stereochemistry of the employed ligand largely influenced the lanthanide emitting processes. Since the ligand chirality finely modified the local coordination environments around the lanthanide center, the use of stereocontrolled ligands is applicable in design of the luminescent lanthanide complexes.
Ibandronate Promotes Autophagy by Inhibiting Rac1–mTOR Signaling Pathway in Vitro and in Vivo

Jie Han,Jian Yang,Qiqi Wang,Xiang Yin,Zewei Sun,Chaoyang Huang,Guoping Chen,Liangrong Zheng,Dongmei Jiang

DOI: https://doi.org/10.1038/s41420-022-00995-6

2022-01-01

Cell Death Discovery

Abstract:We previously reported that ibandronate (IBAN) could improve endothelial function in spontaneously hypertensive rats. However, the mechanism by which IBAN improves endothelial function is unclear. The IBAN-induced autophagic process in vitro experiments were determined by detection of LC3, Beclin1, and P62 protein levels via western blotting. The autophagy flux was detected by confocal microscopy and transmission electron microscopy. For in vivo experiments, spontaneously hypertensive rats were orally administered with IBAN. Utilizing angiotensin II (Ang II) to stimulate the human umbilical vein endothelial cells (HUVECs) and human pulmonary microvascular endothelial cells (HPMECs) as a model of endothelial cell injury in hypertension, we found that IBAN promoted autophagy and protected cell viability in Ang II-treated-endothelial cells while these effects could be reversed by autophagy inhibitor. In terms of mechanism, IBAN treatment decreased the levels of Rac1 and mammalian target of rapamycin (mTOR) pathway. Activating either Rac1 or mTOR could reverse IBAN-induced autophagy. Furthermore, the in vivo experiments also indicated that IBAN promotes autophagy by downregulating Rac1-mTOR. Taken together, our results firstly revealed that IBAN enhances autophagy via inhibiting Rac1-mTOR signaling pathway, and thus alleviates Ang II-induced injury in endothelial cells.
Endothelial Natriuretic Peptide Receptor 1 Play Crucial Role for Acute and Chronic Blood Pressure Regulation by Atrial Natriuretic Peptide

Takeshi TokudomeKentaro OtaniYuanjie MaoLars Jørn JensenYuji AraiTakahiro MiyazakiTakashi SonobeJames T. PearsonTsukasa OsakiNaoto MinaminoJunji IshidaAkiyoshi FukamizuHayato KawakamiDaisuke OnozukaKunihiro NishimuraMikiya MiyazatoHirohito NishimuraDepartment of Biochemistry,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (T.T.,Y.M.,N.M.,M.M.,H.N.)Department of Regenerative Medicine and Tissue Engineering,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (K.O.)Department of Research Promotion and Management,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (Y.A.)Department of Cell Biology,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (T.M.)Department of Cardiac Physiology,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (T.S.,J.T.P.)Department of Preventive Medicine and Epidemiology,National Cerebral and Cardiovascular Center Research Institute,Osaka,Japan. (K.N.)Department of Veterinary and Animal Sciences,Faculty of Health and Medical Sciences,University of Copenhagen,Denmark (L.J.J.).Department of Biochemistry and Molecular Biology,Yamagata University School of Medicine,Japan (T.O.).Life Science Center for Survival Dynamics,Tsukuba Advanced Research Alliance,University of Tsukuba,Ibaraki,Japan (J.I.,A.F.).Department of Anatomy,Kyorin University School of Medicine,Mitaka,Tokyo,Japan (H.K.).Department of Medical Informatics and Clinical Epidemiology,Graduate School of Medical Science,Kyoto Prefectural University of Medicine,Japan (D.O.).Diabetes Institute,Ohio University,Athens (Y.M.).Monash Biomedicine Discovery Institute and Department of Physiology,Monash University,Clayton,Australia (J.T.P.).

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.121.18114

IF: 9.8968

2022-05-11

Hypertension

Abstract:ANP (atrial natriuretic peptide), acting through NPR1 (natriuretic peptide receptor 1), provokes hypotension. Such hypotension is thought to be due to ANP inducing vasodilation via NPR1 in the vasculature; however, the underlying mechanism remains unclear. Here, we investigated the mechanisms of acute and chronic blood pressure regulation by ANP. Immunohistochemical analysis of rat tissues revealed that NPR1 was abundantly expressed in endothelial cells and smooth muscle cells of small arteries and arterioles. Intravenous infusion of ANP significantly lowered systolic blood pressure in wild-type mice. ANP also significantly lowered systolic blood pressure in smooth muscle cell–specific Npr1 –knockout mice but not in endothelial cell–specific Npr1 –knockout mice. Moreover, ANP significantly lowered systolic blood pressure in Nos3 -knockout mice. In human umbilical vein endothelial cells, treatment with ANP did not influence nitric oxide production or intracellular Ca 2+ concentration, but it did hyperpolarize the cells. ANP-induced hyperpolarization of human umbilical vein endothelial cells was inhibited by several potassium channel blockers and was also abolished under knockdown of RGS2 (regulator of G-protein signaling 2), an GTPase activating protein in G-protein α-subunit. ANP increased Rgs2 mRNA expression in human umbilical vein endothelial cells but failed to lower systolic blood pressure in Rgs2 -knockout mice. Endothelial cell–specific Npr1 -overexpressing mice exhibited lower blood pressure than did wild-type mice independent of RGS2, and showed dilation of arterial vessels on synchrotron radiation microangiography. Together, these results indicate that vascular endothelial NPR1 plays a crucial role in ANP-mediated blood pressure regulation, presumably by a mechanism that is RGS2-dependent in the acute phase and RGS2-independent in the chronic phase.

peripheral vascular disease
Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells

Letizia Mezzasoma,Cinzia Antognelli,Vincenzo Nicola Talesa

DOI: https://doi.org/10.1007/s12026-015-8751-0

2015-11-30

Immunologic Research

Abstract:Atrial natriuretic peptide (ANP) is an hormone/paracrine/autocrine factor regulating cardiovascular homeostasis by guanylyl cyclase natriuretic peptide receptor (NPR-1). ANP plays an important role also in regulating inflammatory and immune systems by altering macrophages functions and cytokines secretion. Interleukin-1β (IL-1β) is a potent pro-inflammatory cytokine involved in a wide range of biological responses, including the immunological one. Unlike other cytokines, IL-1β production is rigorously controlled. Primarily, NF-kB activation is required to produce pro-IL-1β; subsequently, NALP3 inflammasome/caspase-1 activation is required to cleave pro-IL-1β into the active secreted protein. NALP3 is a molecular platform capable of sensing a large variety of signals and a major player in innate immune defense. Due to their pleiotropism, IL-1β and NALP3 dysregulation is a common feature of a wide range of diseases. Therefore, identifying molecules regulating IL-1β/NALP3/caspase-1 expression is an important step in the development of new potential therapeutic agents. The aim of our study was to evaluate the effect of ANP on IL-1β/NALP3/caspase-1 expression in LPS/ATP-stimulated human THP1 monocytes. We provided new evidence of the direct involvement of ANP/NPR-1/cGMP axis on NF-kB/NALP3/caspase-1-mediated IL-1β release and NF-kB-mediated pro-IL-1β production. In particular, ANP inhibited both NF-kB and NALP3/caspase-1 activation leading to pro- and mature IL-1β down-regulation. Our data, pointing out a modulatory role of this endogenous peptide on IL-1β release and on NF-kB/NALP3/caspase-1 activation, indicate an important anti-inflammatory and immunomodulatory effect of ANP via these mechanisms. We suggest a possible employment of ANP for the treatment of inflammatory/immune-related diseases and IL-1β/NALP3-associated disorders, affecting millions of people worldwide.

immunology
The influence of personal qualities on performance and progression in a pre-registration nursing programme.

V. Pitt,D. Powis,T. Levett-Jones,S. Hunter

DOI: https://doi.org/10.1016/j.nedt.2013.10.011

IF: 3.906

2014-05-01

Nurse Education Today

Abstract:
Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway

Wared Nour-Eldine,Crystal M. Ghantous,Kazem Zibara,Leila Dib,Hawraa Issaa,Hana A. Itani,Nabil El-Zein,Asad Zeidan

DOI: https://doi.org/10.3389/fphar.2016.00086

IF: 5.6

2016-04-07

Frontiers in Pharmacology

Abstract:INTRODUCTION: Adiponectin (APN), an adipocytokine, exerts protective effects on cardiac remodeling, while angiotensin II (Ang II) induces hypertension and vascular remodeling. The potential protective role of APN on the vasculature during hypertension has not been fully elucidated yet. Here, we evaluate the molecular mechanisms of the protective role of APN in the physiological response of the vascular wall to Ang II.METHODS AND RESULTS: Rat aortic tissues were used to investigate the effect of APN on Ang II-induced vascular remodeling and hypertrophy. We investigated whether nitric oxide (NO), the RhoA/ROCK pathway, actin cytoskeleton remodeling, and reactive oxygen species (ROS) mediate the anti-hypertrophic effect of APN. Ang II-induced protein synthesis was attenuated by pre-treatment with APN, NO donor S-nitroso-N-acetylpenicillamine (SNAP), or cGMP. The hypertrophic response to Ang II was associated with a significant increase in RhoA activation and vascular force production, which were prevented by APN and SNAP. NO was also associated with inhibition of Ang II-induced phosphorylation of cofilin. In addition, immunohistochemistry revealed that 24 h Ang II treatment increased the F- to G-actin ratio, an effect that was inhibited by SNAP. Ang II-induced ROS formation and upregulation of p22(phox) mRNA expression were inhibited by APN and NO. Both compounds failed to inhibit Nox1 and p47(phox) expression.CONCLUSION: Our results suggest that the anti-hypertrophic effects of APN are due, in part, to NO-dependent inhibition of the RhoA/ROCK pathway and ROS formation.

pharmacology & pharmacy
Atrial Natriuretic Peptide Inhibits Cardiomyocyte Hypertrophy Through Mitogen-Activated Protein Kinase Phosphatase-1

D Hayashi,S Kudoh,I Shiojima,YZ Zou,K Harada,M Shimoyama,Y Imai,K Monzen,T Yamazaki,Y Yazaki,R Nagai,I Komuro

DOI: https://doi.org/10.1016/j.bbrc.2004.07.119

IF: 3.1

2004-01-01

Biochemical and Biophysical Research Communications

Abstract:Cardiac hypertrophy is formed in response to hemodynamic overload. Although a variety of factors such as catecholamines, angiotensin II (AngII), and endothelin-1 (ET-1) have been reported to induce cardiac hypertrophy, little is known regarding the factors that inhibit the development of cardiac hypertrophy. Production of atrial natriuretic peptide (ANP) is increased in the hypertrophied heart and ANP has recently been reported to inhibit the growth of various cell types. We therefore examined whether ANP inhibits the development of cardiac hypertrophy. Pretreatment of cultured cardiomyocytes with ANP inhibited the AngII- or ET-1-induced increase in the cell size and the protein synthesis. ANP also inhibited the AngII- or ET-1-induced hypertrophic responses such as activation of mitogen-activated protein kinase (MAPK) and induction of immediate early response genes and fetal type genes. To determine how ANP inhibits cardiomyocyte hypertrophy, we examined the mechanism of ANP-induced suppression of the MAPK activation. ANP strongly induced expression of MAPK phosphatase-1 (MKP-1) and overexpression of MKP-1 inhibited AngII- or ET-1-induced hypertrophic responses. These growth-inhibitory actions of ANP were mimicked by a cyclic GMP analog 8-bromo-cyclic GMP. Taken together, ANP directly inhibits the growth factor-induced cardiomyocyte hypertrophy at least partly via induction of MKP-1. Our present study suggests that the formation of cardiac hypertrophy is regulated not only by positive but by negative factors in response to hemodynamic load.
ANGIOTENSIN II TYPE 1 RECEPTOR MEDIATED CARDIOMYOCYTE AUTOPHAGY INDUCED BY MECHANICAL STRESS THROUGH P38 MAPK

Lin Li,Jianfeng Xu,Yong Ye,Junbo Ge,Yunzeng Zou,Xuebo Liu

DOI: https://doi.org/10.1136/heartjnl-2012-302920a.70

IF: 5.7

2012-01-01

Heart

Abstract:Objectives This study is designated to investigate the mechanism involved in the mechanical stress induced-cardiomyocyte autophagy. Methods We investigated the role of angiotensin II type 1 (AT1)receptor and mitogen-activated protein kinase (MAPK) in mechanical stress-induced autophagic response in cardiomyocytes. LC3b, a marker of autophagy, was detected by western blot analysis. In addition, mice were subjected to transverse aortic constriction (TAC) for 4 weeks to test the effect of autophagy. Results After mechanical stretch stimulation (48 h), neonatal cardiomyocytes expressed hypertrophic responses and remarkable up-regulation of LC3b. While losartan, an AT1 receptor antagonist, not only attenuated cardiac hypertrophy but also abrogated up-regulation of LC3b induced by mechanical stresses. And treatment with PD123319, the AT2 receptor antagonist, did not reverse mechanical stress-induced autophagy. We also investigated the change of activity of MAPK pathway in the autophagy induced by mechanical stress. We found that the phosphorylation of ERK, JNK and p38 were significantly increased after stimulation compared with Control group. The increase of LC3b was significantly blocked by SB 203580, a p38 MAPK inhibitor. However, treatment with PD98059, an ERK inhibitor, or SP600125, a JNK inhibitor, did not abrogate the mechanical stress-induced autophagy. AT1 mediated autophagic and hypertrophic responses were also assessed in vivo. The expression of LC3b in left ventricular cardiomyocyte increased significantly in TAC-operated mice compared with that in sham-operated mice. And losartan significantly inhibited the up-regulation of LC3b induced by chronic pressure overload. Moreover, losartan also ameliorated cardiac remodelling and dysfunction induced by TAC after 4 weeks. Conclusions The results indicate that autophagy in cardiomyocytes induced by mechanical stress is AT1 receptor-dependent, and is through p38 MAPK signal pathway.
GW24-e3170 Angiotensin-(1-7) Downregulates Angiotensin II Type 1 Receptor and Inhibites Mechanical Stress-Induced Cardiomyocyte Autophagy

Lin Li,Xuebo Liu,Jianfeng Xu,Liqing Weng,Junbo Ge,Yunzeng Zou

DOI: https://doi.org/10.1136/heartjnl-2013-304613.240

IF: 5.7

2013-01-01

Heart

Abstract:ObjectivesThe renin-angiotensin system peptides are critically involved in the regulation of autophagy. Angiotensin-(1-7) [Ang-(1-7)] has many beneficial effects in the cardiac remodelling. Here, we tested the hypothesis that Ang-(1-7) has a protective role against the autophagy.MethodsMechanical stress was imposed to cultured cardiomyocytes or heart of mice by in vitro mechanical stretch (MS) orin vivo transverse aorta constriction (TAC) procedures, respectively. Cardiac hypertrophy was evaluated by echocardiography, morphology, immunohistochemistry or animo acid-incorporation rate. Cardiomyocyte autophagy was determined by detecting the expression of LC3b using immunofluorescence staining and Western blot analysis.ResultsMS for 24 hrs and TAC for 4 weeks induced significant in vitro and in vivo cardiac hypertrophy, respectively. Meanwhile, LC3b expression in cardiomyocyte was remarkably upregulated, suggesting the accompanied autophagy with cardiac hypertrophy after mechanical stress. Ang-(1-7) significantly reduced not only cadiomyocyte hypertrophy but also autophagy. Furthermore, MS induced upregulation of AT-R expression either in cultured cardiomyocytes or in hearts of mice and Ang-(1-7) significantly suppressed the upregulation of AT1-R.ConclusionsOur results suggest that Ang-(1-7) may abrogate MS-induced cardiac hypertrophy through downregulation of AT1-R expression.
Cytosolic dynamics of annexin A6 trigger feedback regulation of hypertrophy via atrial natriuretic peptide in cardiomyocytes

Priyam Banerjee,Arun Bandyopadhyay

DOI: https://doi.org/10.1074/jbc.M113.514810

2014-02-28

Abstract:Malfunctions in regulatory pathways that control cell size are prominent in pathological cardiac hypertrophy. Here, we show annexin A6 (Anxa6) to be a crucial regulator of atrial natriuretic peptide (ANP)-mediated counterhypertrophic responses in cardiomyocytes. Adrenergic stimulation of H9c2 cardiomyocytes by phenylephrine (PE) increased the cell size with enhanced expression of biochemical markers of hypertrophy, concomitant with elevated expression and subcellular redistribution of Anxa6. Stable cell lines with controlled increase in Anxa6 levels were protected against PE-induced adverse changes, whereas Anxa6 knockdown augmented the hypertrophic responses. Strikingly, Anxa6 knockdown also abrogated PE-induced juxtanuclear accumulation of secretory granules (SG) containing ANP propeptides (pro-ANP), a signature of maladaptive hypertrophy having counteractive functions. Mechanistically, PE treatment prompted a dynamic association of Anxa6 with pro-ANP-SG, parallel to their participation in anterograde traffic, in an isoform-specific fashion. Moreover, Anxa6 mutants that failed to associate with pro-ANP hindered ANP-mediated protection against hypertrophy, which was rescued, at least partially, by WT Anxa6. Additionally, elevated intracellular calcium (Ca(2+)) stimulated Anxa6-pro-ANP colocalization and membrane association. It also rescued pro-ANP translocation in cells expressing an Anxa6 mutant (Anxa6(ΔC)). Furthermore, stable overexpression of Anxa6(T356D), a mutant with superior flexibility, provided enhanced protection against PE, compared with WT, presumably due to enhanced membrane-binding capacity. Together, the present study delivers a cooperative mechanism where Anxa6 potentiates ANP-dependent counterhypertrophic responses in cardiomyocytes by facilitating regulated traffic of pro-ANP.
Atrial Natriuretic Peptide Ameloriates Diabetic Cardiomyopathy in Insulin-Deficient Rats in Vivo

R. Ritchie,A. Cao,H. Kiriazis,Q. Xu,X. -J. Du,D. M. Kaye

DOI: https://doi.org/10.1016/j.yjmcc.2006.06.051

IF: 5.763

2006-01-01

Journal of Molecular and Cellular Cardiology

Abstract:Diabetic cardiomyopathy is characterised by abnormalities in diastolic function, cardiac hypertrophy and fibrosis. We have demonstrated that diabetic cardiomyopathy in diabetic rats is associated with NADPH oxidase upregulation. The antihypertrophic actions of atrial natriuretic peptide (ANP) in vitro are mediated at least in part by NADPH oxidase suppression. Our objective was to test the hypothesis that ANP limits the functional and structural components of diabetic cardiomyopathy in type 1 diabetes, and elucidate whether antioxidant actions contribute to this protection. ANP treatment (10 pmol/kg/min sc, n=13) over the last 4 weeks of eight weeks streptozotocin diabetes significantly improved left ventricular (LV) diastolic dysfunction, by 22±6% on early/late diastolic filling (echocardiography-derived E/A ratio, P<0.05 vs untreated STZ) and tended to improve LVdP/dtmin by 15±9% (cardiac catheterization, p=0.1). Aortic flow velocity and velocity of circumferential fibre shortening were also improved by ANP, by 19±7% (P<0.05) and 14±6% (P=0.07). No changes in LV systolic pressure or LVdP/dtmax were observed. ANP significantly and potently attenuated LV expression of the hypertrophic gene β-myosin heavy chain (by 69±5%, p<0.001) and of NADPH oxidase (by 79±7%, p<0.05). Aortic NADPH-driven superoxide generation was also decreased by ANP, by 69±5% (P<0.01). Both the ACE inhibitor ramipril (1 mg/kg/day, n=12) and the antioxidant tempol (1.5 mmol/kg/day sc, n=11) improved diastolic, but not systolic, function. Tempol was the only treatment that attenuated cardiac fibrosis. In conclusion, our results demonstrate that ANP ameliorates diabetes-induced disturbances in myocardial function. These studies may lead to new therapies, based on natriuretic peptide and/or antioxidant approaches, for diabetic cardiomyopathy.
Atrial natriuretic peptide protects against gut barrier injury through PLC-γ1/ROS feedback loop in rats following traumatic hemorrhagic shock

Shou-Yin Jiang,Tai-Wen Rao,Ye-Hua Shen,Xiao-Gang Zhao

DOI: https://doi.org/10.1177/1721727x241240948

2024-03-21

European Journal of Inflammation

Abstract:European Journal of Inflammation, Volume 22, Issue , January-December 2024. IntroductionThe mechanisms underlying the protective effects of atrial natriuretic peptide (ANP) on the gut barrier during traumatic hemorrhagic shock (THS) remain elusive. This study aimed to explore the potential role of ANP in safeguarding against gut barrier dysfunction after THS, focusing on the PLC-γ1/ROS feedback loop.MethodsIn our THS rat model, we randomly allocated male Sprague-Dawley rats to receive intravenous ANP with or without a concurrent NADPH oxidase/p38 MAPK inhibitor during the shock phase. After 24 h, we assessed circulatory and jejunal ANP, ROS, intestinal tight junction proteins, and apoptosis to evaluate the effects of ANP on the gut barrier and its interplay with intestinal ANP and ROS. Rat small intestinal epithelial cells (IECs) were also treated with ANP and subjected to hypoxia/re-oxygenation injury, with or without PI3K/PLC inhibition, to elucidate the relationship between ANP/ROS signaling and PLC-γ1. Furthermore, we modulated PLC-γ1 expression in these IECs to examine its impact on ROS and ANP production.ResultsIntravenous ANP administration at 0.025 μg/kg/min during THS significantly increased intestinal ANP and ROS levels at 24 h. ANP treatment enhanced the expression of intestinal tight junction proteins and reduced IEC apoptosis. Inhibition of circulatory ROS diminished intestinal ANP levels, while suppression of circulatory ANP led to a reduction in intestinal ROS. Decreasing PLC-γ1 expression in hypoxia/re-oxygenation-treated IECs resulted in lower ROS and ANP levels, whereas augmenting PLC-γ1 expression did not alter these levels. Additionally, PI3K inhibition markedly decreased PLC-γ1 expression in these cells.ConclusionANP-induced protection of the intestinal barrier in THS is mediated by an intrinsic PLC-γ1/ROS positive feedback loop. ANP preserves gut barrier integrity and reduces IEC apoptosis through this mechanism. Further studies are warranted to investigate the interaction between IECs and other cellular components within the PLC-γ1/ROS loop.

immunology
Beneficial effects of a combination of natural product activators of autophagy on endothelial cells and platelets

Roberto Carnevale,Cristina Nocella,Sonia Schiavon,Vittoria Cammisotto,Maria Cotugno,Maurizio Forte,Valentina Valenti,Simona Marchitti,Daniele Vecchio,Giuseppe Biondi Zoccai,Speranza Rubattu,Ombretta Martinelli,Pasquale Pignatelli,Francesco Violi,Massimo Volpe,Francesco Versaci,Luigi Frati,Giacomo Frati,Sebastiano Sciarretta

DOI: https://doi.org/10.1111/bph.15399

IF: 7.3

2021-04-24

British Journal of Pharmacology

Abstract:Background and PurposeOxidative stress and insufficient autophagy activity are associated with inflammatory processes and are common features of many cardiovascular diseases (CVD). We investigated if a combination of natural activators of autophagy is able to modulate oxidative stress, platelet aggregation and endothelial cell survival and function in response to stress. Experimental ApproachEx vivo platelet aggregation and activation, H2O2 production and autophagy were measured in platelets of subjects at high cardiovascular risk, including smokers, patients with metabolic syndrome (MS) and patients with atrial fibrillation (AF). In vitro, the effects of a mixture of natural pro‐autophagy molecules and antioxidants on platelets and HUVECs were evaluated. Key ResultAutophagy appeared to be inhibited, whereas aggregation was increased in platelets from AF and MS patients and in smokers, as compared to healthy subjects. Treatment of platelets isolated from these patients with 2 different mixtures of catechin, epicatechin, trehalose and spermidine significantly reduced platelet activation and oxidative stress, whereas they increased autophagy in a synergistic manner with respect to the effect of each single molecule alone. Similarly, treatment of HUVECs with a combination of these natural compounds exerted synergic beneficial effects and increased endothelial cell survival, NO bioavailability and angiogenesis in response to stress in a potentiated manner. Conclusion and ImplicationsA combination of natural activators of autophagy could synergistically inhibit platelet activity and oxidative stress and improve endothelial cell survival and function in a potentiated manner representing a useful strategy to reduce the impact of risk factors on CVD occurrence.

pharmacology & pharmacy
C-atrial natriuretic peptide (ANP)4-23 attenuates renal fibrosis in deoxycorticosterone-acetate-salt hypertensive mice

Yuan-Yuan Lu,Shi-Jin Li,Zhong Zhang,Shun He,Yue-Tong Guo,Mo-Na Hong,Shuai Shao,Rui-Qi Wang,Jia Zhang,Ji-Guang Wang,Ping-Jin Gao,Xiao-Dong Li

DOI: https://doi.org/10.1016/j.yexcr.2023.113738

IF: 4.145

2023-10-01

Experimental Cell Research

Abstract:Epithelial-mesenchymal transition (EMT) plays a critical role in hypertension-induced renal fibrosis, a final pathway that leads to end-stage renal failure. C-Atrial natriuretic peptide (ANP)4-23, a specific agonist of natriuretic peptide receptor-C (NPR-C), has been reported to have protective effects against hypertension. However, the role of C-ANP4-23 in hypertension-associated renal fibrosis has not yet been elucidated. In this study, mice were randomly divided into SHAM group, DOCA-salt group and DOCA-salt + C-ANP4-23 group. Renal morphology changes, renal function and fibrosis were detected. Human proximal tubular epithelial cells (HK2) stimulated by aldosterone were used for cell function and mechanism study. The DOCA-salt treated mice exhibited hypertension, kidney fibrosis and renal dysfunction, which were attenuated by C-ANP4-23. Moreover, C-ANP4-23 inhibited DOCA-salt treatment-induced renal EMT as evidenced by decrease of the mesenchymal marker alpha-smooth muscle actin (ACTA2) and vimentin and increase of epithelial cell marker E-cadherin. In HK2 cells, aldosterone induced EMT response, which was also suppressed by C-ANP4-23. The key transcription factors (twist, snail, slug and ZEB1) involved in EMT were increased in the kidney of DOCA-salt-treated mice, which were also suppressed by C-ANP4-23. Mechanistically, C-ANP4-23 inhibited the aldosterone-induced translocation of MR from cytosol to nucleus without change of MR expression. Furthermore, C-ANP4-23 rescued the enhanced expression of NADPH oxidase (NOX) 4 and oxidative stress after aldosterone stimulation. Aldosterone-induced Akt and Erk1/2 activation was also suppressed by C-ANP4-23. Our data suggest that C-ANP4-23 attenuates renal fibrosis, likely through inhibition of MR activation, enhanced oxidative stress and Akt and Erk1/2 signaling pathway.

oncology,cell biology
Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells

P M Baldini,P De Vito,M Fraziano,P Mattioli,P Luly,P Di Nardo

DOI: https://doi.org/10.1002/jcp.10155

Abstract:Atrial natriuretic factor (ANF) is a polypeptide able to affect cardiovascular homeostasis exhibiting diuretic, natriuretic, and vasorelaxant activities. ANF shows antimitogenic effects in different cell types acting through R(2) receptor. Excessive proliferation of smooth muscle cells is a common phenomenon in diseases such as atherosclerosis, but the role of growth factors in the mechanism which modulate this process has yet to be clarified. The potential antimitogenic role of ANF on the cell growth induced by growth factors appears very intriguing. Aim of the present study was to investigate the possible involvement of ANF on rat aortic smooth muscle (RASM) cells proliferation induced by known mitogens and the mechanism involved. Our data show that ANF, at physiological concentration range, inhibits RASM cell proliferation induced by known mitogens such as PDGF and insulin, and the effect seems to be elicited through the modulation of phosphatidic acid (PA) production and MAP kinases involvement.
Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure

Osamu Tsukamoto,Masashi Fujita,Mahoto Kato,Satoru Yamazaki,Yoshihiro Asano,Akiko Ogai,Hidetoshi Okazaki,Mitsutoshi Asai,Yoko Nagamachi,Norikazu Maeda,Yasunori Shintani,Tetsuo Minamino,Masanori Asakura,Ichiro Kishimoto,Tohru Funahashi,Hitonobu Tomoike,Masafumi Kitakaze

DOI: https://doi.org/10.1016/j.jacc.2009.02.038

IF: 24

2009-06-01

Journal of the American College of Cardiology

Abstract:OBJECTIVES: We investigated the functional relationship between natriuretic peptides and adiponectin by performing both experimental and clinical studies.BACKGROUND: Natriuretic peptides are promising candidates for the treatment of congestive heart failure (CHF) because of their wide range of beneficial effects on the cardiovascular system. Adiponectin is a cytokine derived from adipose tissue with various cardiovascular-protective effects that has been reported to show a positive association with plasma brain natriuretic peptide (BNP) levels in patients with heart failure.METHODS: The expression of adiponectin messenger ribonucleic acid (mRNA) and its secretion were examined after atrial natriuretic peptide (ANP) or BNP was added to primary cultures of human adipocytes in the presence or absence of HS142-1 (a functional type A guanylyl cyclase receptor antagonist). Changes of the plasma adiponectin level were determined in 30 patients with CHF who were randomized to receive intravenous ANP (0.025 microg/kg/min human ANP for 3 days, n = 15) or saline (n = 15).RESULTS: Both ANP and BNP dose-dependently enhanced the expression of adiponectin mRNA and its secretion, whereas such enhancement was inhibited by pre-treatment with HS142-1. The plasma adiponectin level was increased at 4 days after administration of human ANP compared with the baseline value (from 6.56 +/- 0.40 microg/ml to 7.34 +/- 0.47 microg/ml, p < 0.05), whereas there was no change of adiponectin in the saline group (from 6.53 +/- 0.57 microg/ml to 6.55 +/- 0.56 microg/ml).CONCLUSIONS: Natriuretic peptides enhance adiponectin production by human adipocytes in vitro and even in patients with CHF, which might have a beneficial effect on cardiomyocytes in patients receiving recombinant natriuretic peptide therapy for heart failure.

cardiac & cardiovascular systems
Endothelial Intracellular ANG (Angiogenin) Protects Against Atherosclerosis by Decreasing Endoplasmic Reticulum Stress

Enyong Su,Peng Yu,Baoli Zhang,Anjing Zhang,Shiyao Xie,Chunyu Zhang,Su Li,Yunzeng Zou,Ming Liu,Hong Jiang,Junbo Ge

DOI: https://doi.org/10.1161/ATVBAHA.121.317339

2022-01-22

Abstract:ANG (angiogenin) is essential for cellular adaptation to endoplasmic reticulum (ER) stress, a process closely associated with cardiovascular diseases, including atherosclerosis. We aimed to investigate the role of ANG in the progression of atherosclerosis and elucidate its underlying molecular mechanisms. We constructed adenoassociated virus 9 ANG overexpression vectors and endothelial ANG- and ApoE (apolipoprotein E)-deficient mice to determine the effects of ANG on ER stress and atherosclerotic lesions. RNA sequencing of endothelial ANG- and ApoE-deficient mice identified ANG-dependent downregulation of ST3GAL5 (ST3 beta-galactoside alpha-2,3-sialyltransferase 5) expression, and the direct regulation of ST3GAL5 by ANG was verified by chromatin immunoprecipitation sequencing and luciferase reporter assay results. Reanalysis of expression profiling datasets indicated decreased ANG levels in patients' atherosclerotic lesions, and these data were validated in aortas from ApoE − /− mice. ER stress marker and adhesion molecule levels, aortic root lesions and macrophage deposition were substantially reduced in ApoE −/− mice injected with an adenoassociated virus 9 ANG without signal peptide (ANG-ΔSP) overexpression vector compared with empty and full-length ANG overexpression vectors. Endothelial ANG deficiency significantly elevated ER stress and increased adhesion molecule expression, which aggravated atherosclerotic lesions and enhanced THP-1 monocyte adhesion to endothelial cells in vivo and in vitro, respectively. Furthermore, ANG-ΔSP overexpression significantly attenuated oxidized low-density lipoprotein-induced ER stress and THP-1 monocyte adhesion to endothelial cells, which were reversed by ST3GAL5 inhibition. These results suggest that endothelial intracellular ANG is a novel therapeutic against atherosclerosis and exerts atheroprotective effects via ST3GAL5-mediated ER stress suppression.
Isosorbide Dinitrate Inhibits Mechanical Stress-Induced Cardiac Hypertrophy and Autophagy Through Downregulation of Angiotensin II Type 1 Receptor.

Li Lin,Jianfeng Xu,Yong Ye,Junbo Ge,Yunzeng Zou,Xuebo Liu

DOI: https://doi.org/10.1097/fjc.0000000000000122

IF: 3.271

2015-01-01

Journal of Cardiovascular Pharmacology

Abstract:Mechanical stress can induce cardiac hypertrophy and autophagy. Recently, it has been reported that nitric oxide donors inhibited autophagy in human chondrocytes. Therefore, the effect of isosorbide dinitrate (ISDN) on cardiac hypertrophy and autophagy induced by mechanical stress was investigated in this study. A 48-hour mechanical stretch and a 4-week transverse aortic constriction were performed to induce cardiomyocyte hypertrophy in vitro and in vivo, respectively, before the assessment of myocardial autophagy using LC3b-II. ISDN was found to significantly reduce mechanical stretch-induced LC3b-II upregulation. Furthermore, mechanical stress was shown to upregulate angiotensin II (AngII) type 1 (AT1) receptor expression in both cultured cardiomyocytes and in mouse hearts, whereas ISDN was demonstrated to significantly suppress the upregulation of the AT1 receptor. It was concluded that ISDN could inhibit mechanical stress-induced cardiac hypertrophy and autophagy through the downregulation of AT1 receptor expression.

The secreted EGF-Discoidin factor xDel1 is essential for dorsal development of the Xenopus embryo.

Atrial Natriuretic Peptide Attenuates Colitis Via Inhibition of the Cgas-Sting Pathway in Colonic Epithelial Cells

Regulation of the Ischemia-Induced Autophagy-Lysosome Processes by Nitrosative Stress in Endothelial Cells.

Luminescent lanthanide complexes with stereocontrolled tris(2-pyridylmethyl)amine ligands: chirality effects on lanthanide complexation and luminescence properties.

Ibandronate Promotes Autophagy by Inhibiting Rac1–mTOR Signaling Pathway in Vitro and in Vivo

Endothelial Natriuretic Peptide Receptor 1 Play Crucial Role for Acute and Chronic Blood Pressure Regulation by Atrial Natriuretic Peptide

Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells

The influence of personal qualities on performance and progression in a pre-registration nursing programme.

Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway

Atrial Natriuretic Peptide Inhibits Cardiomyocyte Hypertrophy Through Mitogen-Activated Protein Kinase Phosphatase-1

ANGIOTENSIN II TYPE 1 RECEPTOR MEDIATED CARDIOMYOCYTE AUTOPHAGY INDUCED BY MECHANICAL STRESS THROUGH P38 MAPK

GW24-e3170 Angiotensin-(1-7) Downregulates Angiotensin II Type 1 Receptor and Inhibites Mechanical Stress-Induced Cardiomyocyte Autophagy

Cytosolic dynamics of annexin A6 trigger feedback regulation of hypertrophy via atrial natriuretic peptide in cardiomyocytes

Atrial Natriuretic Peptide Ameloriates Diabetic Cardiomyopathy in Insulin-Deficient Rats in Vivo

Atrial natriuretic peptide protects against gut barrier injury through PLC-γ1/ROS feedback loop in rats following traumatic hemorrhagic shock

Beneficial effects of a combination of natural product activators of autophagy on endothelial cells and platelets

C-atrial natriuretic peptide (ANP)4-23 attenuates renal fibrosis in deoxycorticosterone-acetate-salt hypertensive mice

Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells

Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure

Endothelial Intracellular ANG (Angiogenin) Protects Against Atherosclerosis by Decreasing Endoplasmic Reticulum Stress

Isosorbide Dinitrate Inhibits Mechanical Stress-Induced Cardiac Hypertrophy and Autophagy Through Downregulation of Angiotensin II Type 1 Receptor.